Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Adherence to Iron Chelation Therapy and Associated Healthcare Resource Utilization and Costs in Medicaid Patients with Sickle Cell Disease

Francis Vekeman, MA, Medha Sasane, BPharm, PhD, Wendy Y Cheng, MPH, MPhil, Agnihotram V Ramanakumar, PhD, Jonathan Fortier, MA, Mei S. Duh, ScD, MPH, Carole Paley, MD, Patricia Adams-Graves, MD

Blood (2014) 124 (21): 2177.

https://doi.org/10.1182/blood.V124.21.2177.2177

Published: 2014

Journal Articles

A Phase 3 Study of L-Glutamine Therapy for Sickle Cell Anemia and Sickle ß 0 -Thalassemia

Yutaka Niihara, MD, Han A. Koh, MD, Lan Tran, MPH, Rafael Razon, MD, Henry Macan, MD, Charles Stark, Pharm.D, Ted Wun, MD, Patricia Adams-Graves, MD

Blood (2014) 124 (21): 86.

https://doi.org/10.1182/blood.V124.21.86.86

Published: 2014

Journal Articles

Comparison of Clinical Outcomes Between Adult and Pediatric Patients (pts) with Sickle Cell Disease (SCD): 3-Year (y) Follow-up in a Prospective, Longitudinal, Noninterventional Registry Trial

Matthew M. Heeney, MD FRCP(C), Brad Baltz, MD, Patricia Adams-Graves, MD, Elizabeth Yang, MD PhD, Carole Paley, MD, Jason Esposito, MSHS, Katie McNamara, MSHS, CCRA, Elliott Vichinsky, MD, Alex George, MD, PhD

Blood (2014) 124 (21): 4890.

https://doi.org/10.1182/blood.V124.21.4890.4890

Published: 2014

Journal Articles

Clinical Outcomes For Patients With Sickle Cell Disease: 24-Month Follow-Up In An Ongoing 3-Year, Prospective, Non-Interventional Registry Trial

Matthew M Heeney, MD, Brigitta U. Mueller, MD, Brad Baltz, MD, Patricia Adams-Graves, MD, Elizabeth Yang, MD, PhD, Carole Paley, MD, Jason Esposito MSHS, McNamara Katie MSHS CCRA, Elliott Vichinsky, MD

Blood (2013) 122 (21): 988.

https://doi.org/10.1182/blood.V122.21.988.988

Published: 2013

Journal Articles

High Resource Utilizers From The Multicenter Compact Study Of Complications In Patients With Sickle Cell Disease and Utilization Of Iron Chelation Therapy

Lanetta B Jordan, MD, MPH, MSPH, Patricia Adams-Graves, MD, Julie Kanter-Washko, MD, Patricia A Oneal, MD, Medha Sasane, BPharm, PhD, Francis Vekeman, MA, Christine Bieri, MBA, Andrea Marcellari, MS, MT(ASCP), Matthew Magestro, MBA, MS, Abigail Adams, BA, Mei S. Duh, ScD, MPH

Blood (2013) 122 (21): 982.

https://doi.org/10.1182/blood.V122.21.982.982

Published: 2013

Journal Articles

Final Results From the Multicenter Compact Study of Complications in Patients with Sickle Cell Disease and Utilization of Iron Chelation Therapy: A Retrospective Medical Records Review.

Lanetta B Jordan, MD, MPH, MSPH, Patricia Adams-Graves, MD, Julie Kanter-Washko, MD, Patricia Ann Oneal, MD, Francis Vekeman, MA, Christine Bieri, MBA, Medha Sasane, BPharm, PhD, Andrea Marcellari, MS, MT(ASCP), Matthew Magestro, MBA, MS, Zachary Gorn, BA, Mei S. Duh, ScD, MPH

Blood (2012) 120 (21): 2106.

https://doi.org/10.1182/blood.V120.21.2106.2106

Published: 2012

Journal Articles

12-Month Follow-up for Patients with Sickle Cell Disease in an Ongoing 3-Year, Prospective, Non-Interventional Registry Trial

Matthew M. Heeney, MD, Brigitta U. Mueller, MD, Brad Baltz, MD, Patricia Adams-Graves, MD, Elizabeth Yang, MD, PhD, Carole Paley, MD, Jason Esposito, MSHS, Elliott P. Vichinsky, MD

Blood (2012) 120 (21): 1010.

https://doi.org/10.1182/blood.V120.21.1010.1010

Published: 2012

Journal Articles

Sickle cell pain: a critical reappraisal

Samir K. Ballas, Kalpna Gupta, Patricia Adams-Graves

Blood (2012) 120 (18): 3647–3656.

https://doi.org/10.1182/blood-2012-04-383430

Published: 2012

Includes: Supplemental data

Journal Articles

Arterial Hypoxemia Syndrome in Sickle Cell Disease.

Patricia Adams-Graves, M. Muthiah, G. Presbury, G. Somes, K. Lamar

Blood (2005) 106 (11): 3801.

https://doi.org/10.1182/blood.V106.11.3801.3801

Published: 2005

Journal Articles

Quality of Life and Sickle Cell Disease.

Patricia Adams-Graves, C. Johnson, P. Corley, K. Lamar

Blood (2005) 106 (11): 1326.

https://doi.org/10.1182/blood.V106.11.1326.1326

Published: 2005

Journal Articles

RheothRx (Poloxamer 188) Injection for the Acute Painful Episode of Sickle Cell Disease: A Pilot Study

Patricia Adams-Graves, Amos Kedar, Mabel Koshy, Martin Steinberg, Robert Veith, Daniel Ward, Rebekah Crawford, Suzanne Edwards, James Bustrack, Martin Emanuele

Blood (1997) 90 (5): 2041–2046.

https://doi.org/10.1182/blood.V90.5.2041

Published: 1997

NARROW

Adherence to Iron Chelation Therapy and Associated Healthcare Resource Utilization and Costs in Medicaid Patients with Sickle Cell Disease

A Phase 3 Study of L-Glutamine Therapy for Sickle Cell Anemia and Sickle ß 0 -Thalassemia

Comparison of Clinical Outcomes Between Adult and Pediatric Patients (pts) with Sickle Cell Disease (SCD): 3-Year (y) Follow-up in a Prospective, Longitudinal, Noninterventional Registry Trial

Clinical Outcomes For Patients With Sickle Cell Disease: 24-Month Follow-Up In An Ongoing 3-Year, Prospective, Non-Interventional Registry Trial

High Resource Utilizers From The Multicenter Compact Study Of Complications In Patients With Sickle Cell Disease and Utilization Of Iron Chelation Therapy

Final Results From the Multicenter Compact Study of Complications in Patients with Sickle Cell Disease and Utilization of Iron Chelation Therapy: A Retrospective Medical Records Review.

12-Month Follow-up for Patients with Sickle Cell Disease in an Ongoing 3-Year, Prospective, Non-Interventional Registry Trial

Sickle cell pain: a critical reappraisal

Arterial Hypoxemia Syndrome in Sickle Cell Disease.

Quality of Life and Sickle Cell Disease.

RheothRx (Poloxamer 188) Injection for the Acute Painful Episode of Sickle Cell Disease: A Pilot Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only